Cell Cycle/Checkpoint
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0.
Targets for Cell Cycle/Checkpoint
- ATM/ATR(26)
- Aurora Kinase(47)
- Cdc42(4)
- Cdc7(4)
- Chk(16)
- c-Myc(20)
- CRM1(8)
- Cyclin-Dependent Kinases(91)
- E1 enzyme(1)
- G-quadruplex(14)
- Haspin(7)
- HMTase(1)
- Kinesin(26)
- Ksp(6)
- Microtubule/Tubulin(243)
- Mps1(15)
- Mitotic(11)
- RAD51(18)
- ROCK(71)
- Rho(13)
- PERK(11)
- PLK(37)
- PTEN(8)
- Wee1(7)
- PAK(21)
- Arp2/3 Complex(8)
- Dynamin(12)
- ECM & Adhesion Molecules(40)
- Cholesterol Metabolism(3)
- Endomembrane System & Vesicular Trafficking(26)
- G1(38)
- G2/M(26)
- G2/S(10)
- Genotoxic Stress(18)
- Inositol Phosphates(18)
- Proteolysis(99)
- Cytoskeleton & Motor Proteins(53)
- Cellular Chaperones(8)
Products for Cell Cycle/Checkpoint
- Cat.No. Product Name Information
- GC15663 LY2606368 LY2606368 (LY2606368) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. LY2606368 inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). LY2606368 causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. LY2606368 shows potent anti-tumor activity.
- GC16822 LY2835219 LY2835219 (LY2835219 methanesulfonate) is a selective CDK4/6 inhibitor with IC50s of 2 nM and 10 nM for CDK4 and CDK6, respectively.
- GC11823 LY2835219 free base A dual inhibitor of Cdk4 and Cdk6
- GC11971 LY2857785 CDK9 inhibitor
- GC33057 LY3295668 (AK-01) LY3295668 (AK-01) (AK-01) is a potent, orally active and highly specific Aurora-A kinase inhibitor, with Ki values of 0.8 nM and 1038 nM for AurA and AurB, respectively.
- GC44100 LysoFP-NH2 LysoFP-NH2 is the fluorescent form of the lysosomal turn-on fluorescent probe for carbon monoxide (CO) lysoFP-NO2.
- GC40021 LysoFP-NO2 LysoFP-NO2 is a turn-on fluorescent probe for carbon monoxide (CO) that localizes to the lysosome.
- GC52358 Malachite Green (chloride) A triphenylmethane dye
- GC41186 Malformin C Malformin C is a natural fungus-derived bicyclic pentapeptide that has antibacterial properties, particularly against species of Bacillus.
- GC61400 MAP4343 MAP4343 is the 3-methylether derivative of Pregnenolone.
- GC62205 Maytansine Maytansine is a highly potent microtubule-targeted compound that induces mitotic arrest and kills tumor cells at subnanomolar concentrations.
- GC32895 Maytansinol (Ansamitocin P-0) Maytansinol (Ansamitocin P-0) inhibits microtubule assembly and induces microtubule disassembly in vitro.
- GC50574 MB 0223 Dynamin-related GTPase DRP1 partial inhibitor
- GC36560 Mc-MMAD Mc-MMAD is a protective group (maleimidocaproyl)-conjugated MMAD. MMAD is a potent tubulin inhibitor. Mc-MMAD is a drug-linker conjugate for ADC.
- GC36561 Mc-MMAE Mc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a drug-linker conjugate for ADC.
- GC18363 Mca-DEVDAPK(Dnp)-OH Mca-DEVDAPK(Dnp)-OH is a fluorogenic substrate for caspase-3.
- GC44132 Mca-PLAC(p-OMeBz)-WAR(Dpa)-NH2 Mca-PLAC(p-OMeBz)-WAR(Dpa)-NH2 is a fluorogenic substrate for matrix metalloproteinase-14 (MMP-14).
- GC34068 McMMAF (Maleimidocaproyl monomethylauristatin F) McMMAF (Maleimidocaproyl monomethylauristatin F) is a protective group-conjugated MMAF. MMAF is a potent tubulin polymerization inhibitor.
-
GC10200
Mdivi 1
A mitochondrial division inhibitor
- GC17649 Mebendazole broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis
- GC49486 Meglutol-d3 An internal standard for the quantification of meglutol
- GC47619 Menaquinone 4-d7 An internal standard for the quantification of menaquinone 4
- GC19244 Mertansine Mertansine (DM1) is a microtubulin inhibitor which binds at the tips of microtubules and suppresses the dynamicity of microtubules..
- GC16607 Mesalamine 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.
- GC61043 Mesalamine impurity P Mesalamine impurity P is an impurity of Mesalamine.
- GC49065 Metacetamol A derivative of acetaminophen
- GC47645 Methidathion An organophosphate insecticide
- GC47646 Methiocarb A carbamate pesticide
- GC47660 Methyl Parathion An organophosphate insecticide
- GC40036 MHAPC-Chol MHAPC-Chol is a cationic cholesterol.
- GC36608 Microtubule inhibitor 1 Microtubule inhibitor 1 is an antitumor agent with microtubule polymerization inhibitory activity, with an IC50 value of 9-16 nM in cancer cells.
- GC13491 Mirin Mirin is a small-molecule inhibitor of MRN (Mre11, Rad50, and Nbs1) complex.
- GC44200 Mitomycin A Mitomycin A is a bacterial metabolite originally isolated from S.
- GC16030 MK-1775 MK-1775 (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC50 of 5.2 nM.
- GC61072 MK-28 MK-28 is a potent and selective PERK activator.
- GC10442 MK-8745 Aurora A inhibitor,potent and selective
- GC16374 MK-8776(SCH-900776) MK-8776(SCH-900776) (MK-8776) is a potent, selective and orally bioavailable inhibitor of checkpoint kinase1 (Chk1) with an IC50 of 3 nM. MK-8776(SCH-900776) shows 50- and 500-fold selectivity over CDK2 and Chk2, respectively.
- GC65143 MKC-1 MKC-1 (Ro-31-7453) is an orally active and potent cell cycle inhibitor with broad antitumor activity. MKC-1 inhibits the Akt/mTOR pathway. MKC-1 arrests cellular mitosis and induces cell apoptosis by binding to a number of different cellular proteins including tubulin and members of the importin β family.
- GC14800 ML 141 Cdc42 GTPase inhibitor
- GC14162 ML167 Clk4 inhibitor,highly selective
- GC32785 ML327 ML327 is a blocker of MYC which can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).
- GC10163 MLN0905 Potent PLK1 inhibitor
- GC13096 MLS-573151 Cdc42 inhibitor
- GC64591 MM41 MM41 is a potent stabilizer of human telomeric and gene promoter DNA quadruplexes. MM41 is potently against the MIA PaCa-2 pancreatic cancer cell line with IC50 value of <10 nM.
- GC15798 MMAD
-
GC63461
MMAE-d8
MMAE-d8 (Monomethyl auristatin E-d8) is a deuterated labeled MMAE, a potent mitotic inhibitor and a tubulin inhibitor.
- GC10034 MMAF Anti-mitotic/anti-tubulin/antineoplastic agent
- GC36633 MMAF Hydrochloride MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A.
- GC38397 MMAF sodium MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A.
- GC63774 MMAF-d8 hydrochloride D8-MMAF hydrochloride is a deuterated form of MMAF hydrochloride, which is a microtubule disrupting agent.
- GC44235 MMP Inhibitor I (trifluoroacetate salt) MMP inhibitor I is a peptide inhibitor of matrix metalloproteinase-1 (MMP-1), MMP-2, and MMP-3 (IC50s = 1.3, 30, and 150 μM, respectively).
-
GC18218
MMP-3 Inhibitor
MMP-3 inhibitor is a peptide inhibitor of matrix metalloproteinase-3 (MMP-3) with a Ki value of 95 nM.
- GC40624 MMP-3 Inhibitor VIII Matrix metalloproteinases (MMPs) belong to a family of proteases that play a crucial role in tissue remodeling and repair by degrading extracellular matrix proteins to enable cell migration.
- GC18616 MMP-8 Inhibitor I MMP-8 Inhibitor I is a selective inhibitor of the neutrophil collagenase matrix metalloproteinase-8 (MMP-8) with an IC50 value of 4 nM.
-
GC14929
Monastrol
Eg5 inhibitor
- GC15592 Moniliformin (sodium salt) induces mitotic arrest at the metaphase stage
-
GC17276
Monomethyl auristatin E
A potent antimitotic compound
- GC45744 monoMICAAc A solvatochromic fluorescent pH probe
- GC15285 MPC 6827 hydrochloride MPC 6827 hydrochloride (MPC-6827 hydrochloride) is a blood brain barrier permeable microtubule-disrupting agent, with potent and broad-spectrum in vitro and in vivo cytotoxic activities. MPC 6827 hydrochloride (MPC-6827 hydrochloride) exhibits potent anticancer activity in human MX-1 breast and other mouse xenograft cancer models. MPC 6827 hydrochloride (MPC 6827 hydrochloride) is a promising candidate for the treatment of multiple cancer types.
- GC10083 MPI-0479605 Mps1 inhibitor,selective and ATP competitive
-
GC11292
Mps1-IN-1
Mps1 kinase inhibitor
- GC50110 Mps1-IN-1 dihydrochloride Selective Mps1 kinase inhibitor
- GC15745 Mps1-IN-2 Mps1 kinase inhibitor
- GC36651 Mps1-IN-3 Mps1-IN-3 is a potent and selective MPS1 kinase inhibitor, with an IC50 of 50 nM.
- GC65339 Mps1-IN-3 hydrochloride Mps1-IN-3 hydrochloride is a potent and selective Mps1 inhibitor with an IC50 value of 50 nM. Mps1-IN-3 hydrochloride can inhibit the proliferation of glioblastoma cells, and effectively sensitizes glioblastomas to Vincristine in orthotopic glioblastoma xenograft model.
- GC40048 MPS1/TTK Inhibitor MPS1/TTK inhibitor is an inhibitor of monopolar spindle 1 (MPS1/TTK; IC50 = 5.8 nM), a kinase involved in mitotic spindle checkpoint signaling that is overexpressed in certain cancerous tumors.
- GC41564 MPT0B014 An inhibitor of tubulin polymerization
- GC36652 MPT0B392 MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line.
- GC62657 MRIA9 MRIA9 is an ATP-competitive, pan Salt-Inducible kinase (SIK) and PAK2/3 inhibitor, with IC50 values of 516 nM, 180 nM and 127 nM for SIK1, SIK2 and SIK3, respectively.
- GC45515 MX1013
- GC66457 MY-875 MY-875 is a competitive microtubulin polymerization inhibitor with an IC50 value of 0.92 μM. MY-875 inhibits microtubulin polymerization by targeting colchicine binding sites and activates the Hippo pathway. MY-875 induces apoptosis and has anticancer activity.
-
GC69516
MY-943
MY-943 is an effective tubulin polymerization and LSD1 inhibitor with anti-cancer activity. MY-943 induces G2/M phase arrest and cell apoptosis, and inhibits cell migration, making it suitable for gastric cancer research.
- GC38589 MYCi361 MYCi361 (NUCC-0196361) is a MYC inhibitor with the Kd of 3.2 μM for binding to MYC. MYCi361 (NUCC-0196361) suppresses tumor growth and enhances anti-PD1 immunotherapy.
- GC38588 MYCi975
- GC60259 MYCMI-6 MYCMI-6 (NSC354961) is a potent and selective endogenous MYC:MAX protein interactions inhibitor. MYCMI-6 blocks MYC-driven transcription and binds selectively to the MYC bHLHZip domain with a Kd of 1.6?μM. MYCMI-6 inhibits tumor cell growth in a MYC-dependent manner (IC50<0.5?μM). MYCMI-6 is not cytotoxic to normal human cells. MYCMI-6 induces apoptosis.
- GC34094 Mycro 3 Mycro 3 is a potent and selective inhibitor of Myc-associated factor X (MAX) dimerization. Mycro 3 also inhibit DNA binding of c-Myc. Mycro 3 could be used for the research of pancreatic cancer.
- GC15773 Myoseverin microtubule-binding molecule
-
GC44260
Myristoyl Coenzyme A (hydrate)
Myristoyl coenzyme A (myristoyl-CoA) is a derivative of CoA that contains the long-chain fatty acid myristic acid.
- GC45958 Myrothecine A A trichothecene mycotoxin
- GC49491 N′-Nitrosonornicotine-d4 An internal standard for the quantification of N’-nitrosonornicotine
- GC49163 N’-Nitrosonornicotine An N-nitrosamine and a carcinogen
- GC45667 N-(p-Tosyl)-GPR-pNA (acetate) A colorimetric thrombin substrate
- GC18445 N-Deacetylcolchicine An inhibitor of microtubule polymerization
- GC44343 n-Decyl-β-D-maltoside n-Decyl-β-D-maltoside is a nonionic surfactant that is commonly used to solubilize and stabilize membrane proteins.
- GC52007 N-hydroxylamine Dapsone An active metabolite of dapsone
- GC49351 N-Nitroso Atenolol A genotoxic derivative of (±)-atenolol
- GC49394 N-Nitroso Fluoxetine A derivative of fluoxetine
- GC49353 N-Nitroso Metoprolol A genotoxic derivative of metoprolol
- GC44430 n-Nonyl-β-D-glucopyranoside n-Nonyl-β-D-glucopyranoside is an anionic alkylglucoside chiral surfactant that is commonly used for the solubilization and crystallization of biological membrane proteins.
- GC45833 N-Oleoyl-L-phenylalanine An N-acyl amide
- GC47806 N-p-Tosyl-Gly-Pro-Lys-pNA (acetate) A colorimetric plasmin substrate
- GC44313 Naphthofluorescein Furin is a proprotein convertase, converting precursor proteins to functional proteins within the Golgi/trans-Golgi secretory pathway.
- GC12491 Narciclasine A plant growth regulator with anticancer activity
- GC49204 Nefazodone-d6 (hydrochloride) An internal standard for the quantification of nefazodone
- GC45523 Nemorosone
- GC10716 Netarsudil (AR-13324) ROCK inhibitor
- GC12515 NMS-1286937 NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM.
- GC36752 NMS-P715 An Mps1/TTK inhibitor
- GC14075 Nocodazole A tubulin production inhibitor,anti-neoplastic agent
- GC47803 Noscapine-13C-d3 An internal standard for the quantification of noscapine